available for iOS, Android & web
March 21, 2014
Reverses earlier negative appraisal
November 11, 2013
But asks for more data to help determine value to NHS
May 12, 2011
Contamination of Johnson & Johnson's HIV drug Prezista (darunavir) with a fungicide has led to a recall of the product in some European countries and Canada.
March 10, 2011
Schizophrenia patients across the European Union are to get access to a new treatment option after European regulators issued a green light for Johnson & Johnson's Xeplion.
January 04, 2011
Janssen-Cilag International has been given the thumbs up by the European Commission for its antipsychotic drug Invega (paliperidone ER) – the first treatment for schizoaffective disorder in Europe.
August 31, 2010
Celgene’s Thalidomide and Janssen-Cilag’s Velcade have been recommended as options to treat patients with multiple myeloma on the National Health Service by its cost regulator.
August 27, 2010
Janssen-Cilag is to appeal the UK decision to restrict access to its multiple myeloma drug Velcade (bortezomib).
Making patients smile
Patients’ wellbeing can be just as important as
International Clinical Researcher of the Year 2016
Book your tickets today!
PharmaTimes 2015 Copyright | RSS Feed Subscriptions